Among these, IL-1β as well as IL-6 emerged as particularly significant markers, especially in long COVID-19 patients, pointing towards their key role in driving persistent inflammation and ongoing symptoms following the acute phase of infection [73]. The gene discussed is IL1B; the disease is COVID-19.